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ABSTRACT
Saikosaponin a (SSa), a bioactive phytochemical from Bupleurum, triggers 
sequential caspase-2 and caspase-8 activation, and thereby induces caspase-mediated 
apoptosis in human colon carcinoma (HCC) cells. However, the upstream mechanism 
of caspase-2 activation remains unknown. Therefore, we investigated the signaling 
mechanisms underlying SSa-induced caspase activation and apoptosis in HCC cells. 
SSa treatment triggered marked antitumor effects, especially in HCC cells, in a 
cell culture model and a mouse xenograft model. SSa also induced the activation 
of several endoplasmic reticulum (ER) stress signals. Specifically, caspase-4, a 
critical regulator of ER stress-induced apoptosis, was activated significantly after 
SSa treatment. Mechanistically, selective inhibition of caspase-4 suppressed SSa-
induced apoptosis, colony inhibition, and the activation of caspase-3, -8, and -2, but 
not vice versa. Consistent with the important role of caspase-2 in the DNA damage 
response, SSa induced DNA damage, as evidenced by a cytokinesis-block micronucleus 
assay, single-cell gel electrophoresis, and an increase in the levels of γ-H2AX, a DNA 
damage marker. Moreover, inhibition of caspase-4 activation inhibited SSa-induced 
histone H2AX phosphorylation. Taken together, these results suggest that caspase-4 
is an upstream regulator of SSa-induced DNA damage and caspase activation in HCC 
cells. Given that SSa-induced apoptosis appeared to be specific to certain cell types 
including HCC cells, SSa may be a promising cancer therapy agent in certain types 
of cancer.
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INTRODUCTION
Human caspase-4 and mouse caspase-12, which are 
localized in the endoplasmic reticulum (ER), are cleaved 
by ER stress-inducing agents and are involved in the ER 
stress response [1-3]. Although the function of caspase-4 
is not fully understood, it is believed to play a critical 
role in the activation of inflammasomes [4], which are 
components of the immune system. Caspase-4 is also 
involved in Fas- and TRAIL-induced apoptosis [5, 6]. 
Moreover, caspase-4 activation is essential for ER stress-
induced apoptosis in some cell lines [1, 7-9]. However, 
at least one study has suggested that caspase-4 is not 
essential for ER stress-induced apoptosis [10]; therefore, 
the role of caspase-4 in ER stress-induced apoptosis 
remains unclear.
Saikosaponin a (SSa), a triterpenoid glycoside 
from Bupleurum, exhibits various biological activities, 
such as anti-inflammatory, analgesic, neuromodulatory, 
antifibrotic, antiepileptic, and anti-cancer activity. SSa 
can inhibit cell growth and DNA synthesis, and induce 
apoptosis [11-13]. Previously, our group found that SSa 
could induce the activation of various caspases and poly 
(ADP-ribose) polymerase (PARP), decrease Bcl-2 and 
X-linked inhibitor of apoptosis (XIAP) expression, and 
induce apoptosis in human colon carcinoma (HCC) cells 
[14]. In addition, SSa has been shown to have cytotoxicity 
against human gastric cancer, breast cancer, and hepatoma 
[15-18].
Caspase-2, one of the most evolutionarily conserved 
caspases, has multiple functions in response to DNA 
damage [19, 20]. Caspase-2 deficiency leads to genetic 
instability and triggers an aberrant DNA damage response 
[21]. Specifically, some studies have shown that caspase-2 
is necessary for DNA damage-induced apoptosis [19-23]. 
Previously, we showed that sequential caspase-2 and -8 
activation was important for SSa-induced apoptosis in 
HCC cells [14]. Although caspase-2 is generally classified 
as an initiator caspase, its cleavage specificity is closer to 
the effector caspases, such as caspase-3 and -7 [24].
In our study, we found that SSa triggered apoptotic 
cell death in a cell type-specific manner and was 
dependent on caspase-4 activation. Our results also show 
that caspase-4 is an upstream regulator of DNA damage 
response and/or DNA damage-mediated sequential 
caspase-2 and -8 activation.
RESULTS
SSa triggers cell type-dependent cell death
According to previous studies [15-17], SSa 
has cytotoxic effects against some breast carcinoma 
and hepatoma carcinoma cells. We also reported SSa 
cytotoxicity in HCC cells [14]. To investigate whether SSa 
has universal cytotoxicity in cancer cells, various cancer 
cells from different tissue types were treated with SSa. 
As shown in Figure 1, when exposed to SSa, all colon 
cancer cell populations showed significantly decreased 
cell viability, whereas lung cancer cell populations except 
H358, breast cancer cell populations except MCF-7, 
and leukemia cell populations except Jurkat and K562 
exhibited minimally decreased cell viability. The same 
results were obtained when cell lines were assayed for 
apoptosis using sub-G1 fraction analysis and Hoechst 
33342 staining (data not shown). These results indicate 
that SSa can trigger apoptotic cancer cell death in a cell 
type-dependent manner. Since SSa reduced cell viability in 
all HCC cell lines, SSa may be effective for the treatment 
of colon cancer. Additionally, SSa concentrations of less 
than 10 μM had little to no effect on the cell viability of 
all colon cancer cell lines tested (Supplementary Figure 
1). At 10 μM and 15 μM, SSa caused mild and moderate 
cytotoxicity, respectively. Because 20 μM SSa led to 
significant cytotoxicity in all colon cancer cells tested, 
we used this concentration for subsequent experiments. 
Thus, there were both dose-dependent and time-dependent 
decreases in cell viability in the presence of SSa.
Prolonged inhibition of tumor growth in a colon 
carcinoma xenograft model with SSa treatment
To evaluate the in vivo antitumor effects of SSa in 
xenograft models, BALB/c nude mice bearing LoVo or 
SW480 colon carcinomas on their rear flanks were treated 
with 2 mg/kg of intraperitoneal SSa once per week. 
Control mice received injections of the same volume 
of the vehicle (10% DMSO in PBS, pH 7.4). In mice 
treated with SSa, prolonged tumor growth inhibition was 
observed (Figure 1E). The difference between vehicle-
treated groups and SSa-treated groups was notable by 
days 9–12. To verify that SSa treatment had no effect on 
healthy tissues, we looked for histological changes after 
the administration of SSa. We found no histopathological 
signs of damage, such as inflammation of lung, spleen, 
liver, or kidney tissues after treatment (data not shown).
SSa activates caspase-4
SSa and its epimer, saikosaponin d are major 
triterpenoid saponin derivatives. Because saikosaponin d 
induces ER stress [25], SSa may also trigger ER stress 
in HCC cells. To assess this possibility, we investigated 
several ER-specific signals. SSa increased the expression 
of ER stress and unfolded protein response genes such 
as PERK, CHOP, ATF4, and XBP1 in some HCC cells 
(Supplementary Figure 2). Protein expression assays 
revealed that levels of CHOP, but not phosphorylated 
PERK (Thr981) or phosphorylated eIF2α (Ser51), were 
increased in response to SSa and were cell type-dependent 
(Figure 2A). For antibody validation, the combination 
of niflumic acid (100 μM) and ciglitazone 7.5 μM was 
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employed as a positive control, as it has been shown to 
induce significant phosphorylation of PERK and eIF2α 
in A549 lung cancer cells in previous research [26]. 
Interestingly, cleavage of ER-resident caspases, such as 
caspase-4 and -12, by SSa treatment was significant in all 
HCC cells (Figure 2A). Moreover, tumor lysates obtained 
Figure 1: Effect of SSa on cell viability. Human colon cancer (A), lung cancer (B), breast cancer (C), and leukemia (D) cell lines were 
treated with 20 μM SSa for up to 40 h. Cell viability was assessed using Trypan Blue. Values on the y-axis are surviving cells as a percentage 
of the total population after SSa treatment. Results are the mean ± standard error from three experiments. *P < 0.05 and **P < 0.01 compared 
with the 0-h control. The Mann-Whitney U test was used for statistical analysis. (E) Nude mice (6 weeks old) with subcutaneous LoVo 
or SW480 colon carcinoma xenografts (65–80 mm3) were pretreated with a vehicle (10% DMSO in PBS, pH 7.4) or SSa (2 mg/kg) once 
weekly beginning on day 0. Data shown represent the mean ± standard errors of two independent experiments, each using five mice per 
group.
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from LoVo and SW480 xenograft mice treated with SSa 
for 10 days also showed cleavage of caspase-4 (data 
not shown). Next, we investigated if SSa could increase 
caspase-4 enzymatic activity. To do this, caspase-4 
protease activity was measured using LEVD-pNA, a 
colorimetric labeled substrate specific for caspase-4. As 
shown in Figure 2B, SSa activated caspase-4 in a time-
dependent manner in human LoVo, SW480, HT29, and 
SW620 cells.
Caspase-4 inhibition suppresses SSa-induced 
activation of caspase-3, caspase-2, and caspase-8, 
but not vice versa
SSa was shown to induce activation of caspase-3, -8, 
and -2 in HCC cells in our previous study [14]. Therefore, 
we examined whether SSa-induced caspase-4 activation 
was linked with the activation of other caspases. To this 
end, we used SW480 cells, which we already showed had 
activated caspase-3, -8, and -2 in the presence of SSa [14]. 
As shown in Figure 3A-3C, caspase activities (caspase-3, 
-8, and -2) were enhanced after SSa treatment. However, 
these effects were attenuated efficiently by treatment 
with caspase-4 inhibitors (z-LEVD-fmk and Ac-LEVD-
CHO). The same results were obtained in LoVo cells 
(data not shown). Moreover, SSa-induced cleavage of 
caspase-2 and -8 and Bid truncation (called t-Bid), which 
is a downstream event of caspase-8 activation, were also 
inhibited significantly by the caspase-4 inhibitor z-LEVD-
fmk in both LoVo and SW480 cells (Supplementary 
Figure 3). To confirm these results, caspase-4 was 
silenced using siRNA. Western blot analysis indicated 
efficient knockdown of caspase-4 (Supplementary Figure 
4). Consistent with results in Figure 3A-3C, siRNA 
against caspase-4 suppressed SSa-induced activation of 
caspase-3, -8, and -2 (Figure 3D). However, SSa-induced 
enhancement of caspase-4 activity was not attenuated 
by z-DEVD-fmk (caspase-3 inhibitor), z-VDVAD-fmk 
(caspase-2 inhibitor), or z-IETD-fmk (caspase-8 inhibitor) 
(Figure 3E). Likewise, caspase-3, -2, and -8 knockdown 
also did not suppress SSa-induced caspase-4 cleavage 
or enzymatic activation (data not shown). These results 
suggest that caspase-4 activation occurred upstream of 
other caspases including caspase-2.
SSa causes apoptosis in a dose-dependent 
manner
In our previous study [14], we evaluated SSa-
induced apoptosis by analyzing sub-G1 fraction and 
by Hoechst 33342 staining. Here, we also performed 
annexin V binding assay to detect redistribution of 
phosphatidylserine, which is a hallmark for early 
apoptosis. We treated LoVo and SW480 cells with a range 
of SSa concentrations. SSa-treated HCC populations 
contained more annexin V-positive cells as well as more 
cells with sub-G1 DNA content or condensed/fragmented 
nuclei compared with the DMSO control (Supplementary 
Figure 5), indicating that SSa induced dose-dependent 
apoptosis in HCC cells. Furthermore, SSa caused dose-
dependent apoptosis in H358 (the only SSa-sensitive lung 
cancer cells identified in our experiments) lung cancer 
cells but not in H1299 (SSa-resistant cells) lung cancer 
cells, confirming that SSa-induced apoptosis was cell 
type-specific (Supplementary Figure 5).
Inhibition of caspase-4 suppresses SSa-induced 
apoptosis
Next, to examine the role of caspase-4 in SSa-
induced apoptosis, LoVo and SW480 cells were pre-
incubated with caspase-4 inhibitors, z-LEVD-fmk 
or Ac-LEVD-CHO, before exposure to 20 μM SSa. 
We performed sub-G1 fraction analysis and Hoechst 
33342 staining to quantify cells with characteristics 
of apoptosis. Pre-incubation with z-LEVD-fmk or Ac-
LEVD-CHO significantly attenuated SSa-induced 
increases in the number of apoptotic cells in both LoVo 
and SW480 cells (Figure 4A and 4C). A significant 
increase in the percentage of cells in the sub-G1 fraction 
was observed in SSa-treated LoVo and SW480 cells 
(61.7 ± 6.5 and 56.2 ± 3.4%, respectively). However, the 
percentage of cells in the sub-G1 fraction was decreased 
significantly with z-LEVD-fmk (19.2 ± 3.2 for LoVo; 
18.8 ± 1.7% for SW480) and Ac-LEVD-CHO (23.0 
± 2.1 for LoVo; 20.6 ± 2.2% for SW480) treatment. A 
significant increase in cells with condensed/fragmented 
nuclei (determined using Hoechst 33342 staining) was 
also observed in SSa-treated LoVo and SW480 cells 
(53.7 ± 4.5 and 48.6 ± 4.8%, respectively), whereas the 
percentage of cells with condensed/fragmented nuclei 
decreased significantly with z-LEVD-fmk (14.2 ± 2.2 
and 12.8 ± 1.3%, respectively) and Ac-LEVD-CHO 
(17.3 ± 3.1 and 15.3 ± 2.3%, respectively) treatment. 
Additionally, siRNA against caspase-4 suppressed SSa-
induced apoptosis (Figure 4B and 4D), consistent with 
the results shown in Figure 4A and 4C. A significant 
increase in the percentage of cells in the sub-G1 fraction 
was observed in SSa-treated LoVo and SW480 cells 
(64.8 ± 3.6 and 57.0 ± 1.8%, respectively), whereas the 
percentage of cells in the sub-G1 fraction decreased 
significantly with knockdown of caspase-4 (34.4 ± 6.9 
and 19.1 ± 2.9%, respectively). A significant increase in 
cells with condensed and/or fragmented nuclei was also 
observed when LoVo and SW480 cells were treated with 
SSa (50.3 ± 7.0 and 52.0 ± 3.2%, respectively). However, 
these numbers decreased significantly on knockdown 
of caspase-4 (23.7 ± 3.5 for LoVo; 15.6 ± 0.7% for 
SW480). These results indicate that caspase-4 activation 
is intimately linked with the onset of SSa-induced 
apoptosis. Moreover, given that activation of caspase-2, 
-8, and -3 is essential for SSa-induced apoptosis [14], 
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these results indicate that the sequential activation of 
caspase-4, -2, -8, and -3 is a critical step in SSa-induced 
apoptosis. However, neither the selective caspase-12 
inhibitor z-ATAD-fmk (Supplementary Figure 6) nor 
caspase-12 siRNA (data not shown) attenuated SSa-
induced apoptosis.
Figure 2: SSa-induced caspase-4 activation in HCC cells. LoVo, SW480, HT29, and SW620 cells were treated with 20 μM SSa 
for the indicated times. (A) Levels of phosphorylated PERK (Thr981), phosphorylated eIF2α (Ser51), CHOP, pro-caspase-4, cleaved-
caspase-4, and pro-caspase-12 were analyzed by Western blotting. Blots are representative of three independent experiments, and data 
shown represent the mean ± standard error of three independent experiments. **P < 0.01 compared with the 0-h control. The Mann-Whitney 
U test was used for statistical analysis. A549 lung cancer cell lysate treated with the combination of niflumic acid (100 μM) and ciglitazone 
7.5 μM for 30 h was used as a positive control for the phosphorylation of PERK and eIF2α. (B) Changes in caspase-4 activity were 
monitored via detection of liberated pNA from the substrate, LEVD-pNA. All samples were measured in triplicate. Each column represents 
the mean ± standard error of three independent experiments. *P < 0.05 and **P < 0.01 compared with the 0-h control. The Mann-Whitney 
U test was used for statistical analysis.
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Caspase-4 inhibition increases clonogenic 
survival of colon carcinoma cells in response to 
SSa treatment
Because caspase-4 inhibitors (z-LEVD-fmk and 
Ac-LEVD-CHO) inhibited SSa-induced apoptosis, 
we examined whether these inhibitors could restore 
clonogenic survival to SSa-treated colon cancer cells. 
The addition of caspase-4 inhibitors to SSa-treated cells 
increased clonogenic survival significantly (Figure 4E). 
Compared with untreated cells, SSa-treated cells had fewer 
LoVo (12.1 ± 1.1%) and SW480 (17.2 ± 2.3%) colonies, 
Figure 3: Caspase-4 plays a role in SSa-induced caspase-2, -8, and -3 activation. (A–C, E) SW480 cells were treated with 20 
μM SSa for 15 h in the presence or absence of caspase-3 inhibitor (z-DEVD-fmk, labeled DEVD-f; 10 μM), caspase-8 inhibitor (z-IETD-
fmk, labeled IETD-f; 10 μM), caspase-2 inhibitor (z-VDVAD-fmk, labeled VDVAD-f; 10 μM), or caspase-4 inhibitors (z-LEVD-fmk and 
Ac-LEVD-CHO, labeled LEVD-f and LEVD-C, respectively; each 10 μM). The activities of caspase-3 (A), caspase-8 (B), caspase-2 (C), 
and caspase-4 (E) were monitored via the detection of pNA liberated from DEVD-pNA, IETD-pNA, VDVAD-pNA, and LEVD-pNA, 
respectively. Each column represents the mean ± standard error of three independent experiments. **P < 0.01 compared with untreated 
controls. †P < 0.05 and ††P < 0.01 compared with SSa alone. ANOVA and Tukey’s test were used for statistical analysis. (D) SW480 cells 
were seeded and allowed to reach ~30% confluence on the day of transfection. Cells were treated with siRNA to caspase-4 or scramble 
siRNA (each 20 nM) for 30 h, and then exposed to 20 μM SSa for 15 h. Caspase-4 knockdown efficiency was confirmed by Western 
blotting. Caspase-3, -8, and -2 activities were monitored as in Figure 3A–C. Each column represents the mean ± standard error of three 
independent experiments. ††P < 0.01 compared with SSa alone. The Mann-Whitney U test was used for statistical analysis.
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Figure 4: Role of caspase-4 in SSa-induced apoptosis and loss of clonogenic survival. (A and C) LoVo and SW480 cells 
were treated with 20 μM SSa for 30 h (for sub-G1 fraction analysis) or 24 h (for Hoechst 33342 staining) in the presence or absence of the 
caspase-4 inhibitors z-LEVD-fmk (LEVD-f; 10 μM) and Ac-LEVD-CHO (LEVD-C; 10 μM). (A) Cell cycle analysis was used to quantify 
apoptosis as the percentage of cells in the sub-G1 fraction. Each column represents the mean ± standard error from three experiments. 
**P < 0.01 compared with untreated controls. †P < 0.05 and ††P < 0.01 compared with SSa alone. ANOVA and Tukey’s test were used for 
statistical analysis. (C) Morphologically apoptotic cells were quantified after Hoechst 33342 staining. Each column represents the mean ± 
standard error of cells with condensed/fragmented nuclei in three independent experiments. **P < 0.01 compared with untreated controls. 
†P < 0.05 and ††P < 0.01 compared with SSa alone. ANOVA and Tukey’s test were used for statistical analysis. Representative images of 
Hoechst 33342 staining are shown. (B and D) LoVo and SW480 cells were seeded and allowed to reach ~30% confluence on the day of 
transfection. Cells were treated with siRNA of caspase-4 (si-C4; 20 nM) or scrambled siRNA (si-Cont; 20 nM) for 30 h and then exposed to 
20 μM SSa for 30 h (for sub-G1 fraction analysis) or 24 h (for Hoechst 33342 staining). Caspase-4 knockdown efficiency was confirmed via 
Western blotting. (B) Apoptosis was quantified as in Figure 4A. Each column represents the mean ± standard error from three experiments. 
**P < 0.01 compared with untreated controls. †P < 0.05 and ††P < 0.01 compared with SSa alone. ANOVA and Tukey’s test were used for 
statistical analysis. (D) Morphologically apoptotic cells were quantified as in Figure 4C. Each column represents the mean ± standard error 
of three independent experiments. **P < 0.01 compared with untreated controls. †P < 0.05 and ††P < 0.01 compared with SSa alone. ANOVA 
and Tukey’s test were used for statistical analysis. Representative images of Hoechst 33342 staining are shown. (E) LoVo and SW480 
cells were treated with 15 μM SSa in the presence or absence of the caspase-4 inhibitors, z-LEVD-fmk (10 μM), and Ac-LEVD-CHO (10 
μM). After 12 (for LoVo) or 14 (for SW480) days of incubation, cells were analyzed for cloning efficiency. The number of colonies was 
expressed as a percentage of the untreated control. Each column represents the mean ± standard error of three independent experiments. **P 
< 0.01 compared with untreated controls. ††P < 0.01 compared with SSa alone. ANOVA and Tukey’s test were used for statistical analysis.
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and the addition of z-LEVD-fmk (54.3 ± 5.3% for LoVo; 
65.8 ± 3.6% for SW480) or Ac-LEVD-CHO (49.8 ± 4.5% 
for LoVo; 58.2 ± 2.3% for SW480) to SSa-treated cells 
increased the number of colonies significantly. These 
results suggest that the efficiency of clonogenic cell 
eradication by SSa is dependent on caspase-4 activation. 
On the other hand, the caspase-12 inhibitor z-ATAD-fmk 
did not attenuate SSa-triggered eradication of clonogenic 
cells (data not shown).
SSa induces micronucleus formation in HCC 
cells
ER stress is associated with DNA damage. Given 
that SSa activates caspase-2 [14], which has been 
implicated in the regulation of cell death induced by 
DNA damage and ER stress [19, 20, 22, 23, 27, 28], we 
evaluated the effects of SSa on DNA damage and on 
ER stress. First, formation of micronuclei was used as 
a biological indicator of SSa-induced genotoxicity. The 
frequency of micronucleus (MN) formation increased 
after SSa treatment (Figure 5A and Supplementary Figure 
7). After treatment with SSa for 0, 8, and 15 h, average 
MN frequencies were 13, 33, and 78 per 1000 binucleated 
cells for LoVo cells, and they were 11, 31, and 64 for 
SW480 cells, in three independent experiments. These 
results showed that SSa-induced MN formation was time-
dependent.
SSa induces an increase in the Olive tail moment 
(OTM) of HCC cells
To further investigate the prevalence of DNA 
damage, we performed neutral (for DSBs) and alkaline 
(for SSBs and DSBs) versions of the single-cell gel 
electrophoresis (SCGE, comet) assay. After treatment 
with SSa, neutral comet assay results indicated a time-
dependent increase in DNA fragmentation in the OTM, 
indicating the presence of DSBs (Figure 5B, right panel 
and Figure 5C). Alkaline comet assay results showed that 
time-dependent increases in SSa-induced SSBs and DSBs 
in the OTM were more pronounced and were statistically 
significant (Figure 5B, left panel). The mean percentage 
of cells with OTM > 5 is shown in Supplementary Figure 
8. These data indicate that SSa caused both SSBs and 
DSBs in HCC cells. The significance of this effect was 
determined by comparing the DNA quantity and the mean 
distance of migration in the tail.
SSa induces the formation of γ-H2AX foci
Phosphorylation of H2AX at Ser139 occurs after 
DNA damage and is an excellent marker of DNA DSBs 
[29-31]. Studies have shown that phosphorylated H2AX 
(called γ-H2AX) is visible as nuclear foci at sites of DNA 
damage; therefore, we performed immunostaining to 
ascertain the presence of γ-H2AX foci at sites of DNA 
DSBs. Using LoVo and SW480 cells, we observed a 
significantly greater number of γ-H2AX foci-positive cells 
in SSa-treated cells than in untreated control cells (Figure 
5D and Supplementary Figure 9). This was confirmed 
by Western blotting using anti-phospho-H2AX antibody. 
Time-dependent H2AX phosphorylation at Ser139 after 
SSa treatment was observed in these cancer cells (Figure 
5E). Moreover, tumor lysates obtained from LoVo and 
SW480 xenograft mice treated with SSa for 10 days 
also showed H2AX phosphorylation (data not shown). 
Collectively, these results show that SSa triggers DNA 
damage in HCC cells.
Caspase-4 inhibition suppresses SSa-induced 
ã-H2AX foci formation
Considering the role of caspase-4 in SSa-induced 
caspase-2 activation and the role of caspase-2 in the 
DNA damage response, we investigated the role of 
caspase-4 in SSa-induced DNA damage in LoVo and 
SW480 cells. As shown in Figure 6A, γ-H2AX foci 
were increased markedly by SSa treatment, and these 
increases were suppressed significantly by the caspase-4 
inhibitor z-LEVD-fmk. Western blot analysis using anti-
phospho-H2AX antibody also showed that z-LEVD-fmk 
inhibited SSa-induced H2AX phosphorylation at Ser139 
(Figure 6B). However, neither z-VDVAD-fmk, z-IETD-
fmk nor z-DEVD-fmk inhibited SSa-induced H2AX 
phosphorylation at Ser139 (data not shown). These results 
indicate that caspase-4 may be a critical regulator of the 
DNA damage response in SSa-treated cells.
DISCUSSION
Previously, we reported that SSa triggered apoptotic 
cell death in HCC cells through the sequential activation of 
caspase-2 and caspase-8 [14]. In this study, we expanded 
our findings to other cell types and demonstrated a 
critical role for caspase-4 in SSa-induced apoptosis and 
the DNA damage response. Because our previous results 
and other research have shown that SSa induced cancer 
cell death [14, 15, 17, 18], we first evaluated whether SSa 
cytotoxicity was universal. Cell viability assays showed 
that SSa cytotoxicity was cell type-dependent. Although 
colon cancer cells were very sensitive to SSa-triggered 
cytotoxicity, the majority of lung cancer, breast cancer, 
and leukemia cells were resistant to SSa. Moreover, at 
a clinically achievable concentration (2 mg/kg, once 
weekly), SSa significantly delayed colon cancer growth in 
a nude mouse xenograft model, supporting the possibility 
of a clinical application for SSa in colon cancer therapy.
ER stress is known to be a critical initiator and 
activator of cell death in pathological conditions [32-35]. 
ER stress, which results from the accumulation of unfolded 
or misfolded proteins in the ER lumen, has a profound 
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effect on cancer cells. Therefore, pharmacological 
aggravation of ER stress has become an attractive strategy 
for cancer therapy. Potential anticancer agents, such as 
bortezomib, falcarindiol, curcumin analog, oplopantriol 
A, and WZ35, exert their activities by triggering ER stress 
[28, 36-39]. To investigate the possible effects of SSa 
on ER stress, the levels of various ER stress-associated 
proteins were assessed. PERK and PERK-induced 
phosphorylation of eIF2α initiates the early ER stress 
response and represses protein biosynthesis, preventing 
the influx of ER client proteins [40-42]. The transcription 
factor CHOP (C/EBP homologous protein) is activated 
by ER stress and is a component of the ER-mediated 
apoptosis pathway [43, 44]. Two ER-resident cysteine 
proteases (caspase-4 and caspase-12) are also activated 
by ER stress [1, 2]. There are conflicting reports on the 
role of these two caspases in ER stress-induced apoptosis. 
Some studies have shown that they are implicated in ER 
stress-induced apoptosis [1-3, 5-9]; however, at least one 
study has reported that these less recognized caspases are 
not required for ER stress-induced apoptosis [10]. SSa 
treatment did not trigger the phosphorylation of PERK 
Figure 5: DNA damage induced by SSa treatment of human colon cancer (HCC) cells. LoVo and SW480 cells were treated 
with 20 μM SSa for the indicated times. The micronucleus (MN) test, single-cell gel electrophoresis (SCGE, comet) assay, and ã-H2AX foci 
assay were used to evaluate genotoxicity associated with SSa exposure. (A) MN frequency was determined by analysis of 1000 binucleated 
cells from each sample. Results are the mean ± standard error from three experiments. *P < 0.05 and **P < 0.01 compared with the 0-h 
control. The Mann-Whitney U test was used for statistical analysis. (B) Alkaline and neutral SCGE assays were performed according to 
standard protocols. A computerized imaging system was used to score and measure DNA comets (OTM). Results are the mean ± standard 
error from three experiments. *P < 0.05 and **P < 0.01 compared with the 0-h control. The Mann-Whitney U test was used for statistical 
analysis. (C) Representative images of SYBR Green staining (1 μg/mL) from the neutral SCGE assay. (D) Following SSa treatment for 15 
h, anti-phospho-H2AX (Ser139) primary antibody and AlexaFluor 594 secondary antibody were used to immunostain LoVo and SW480 
cells. The percentage of cells positive for γ-H2AX foci is shown. Results shown are the mean ± standard error from three experiments. 
**P < 0.01 compared with the DMSO control. The Mann-Whitney U test was used for statistical analysis. (E) Western blotting was used 
to detect H2AX phosphorylation at Ser139. Blots are representative of three independent experiments, and data shown represent the mean 
± standard error of three independent experiments. **P < 0.01 compared with the 0-h control. The Mann-Whitney U test was used for 
statistical analysis.
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or eIF2α in any of the colon cancer cell lines tested and 
increased CHOP expression in a cell type-dependent 
manner. Interestingly, SSa induced cleavage of caspase-4 
and -12 and enzymatic activation of caspase-4 in all cell 
lines tested.
Recently, Flood et al. reported robust expression 
of caspase-4 and -5 within neoplastic tissue of colorectal 
tumors [45]. We examined the expression of caspase-4 in 
various cancer cells and found that caspase-4 expression 
was significantly higher in colon cancer cells than in 
other cancer cells (Supplementary Figure 10). Among 
lung cancer cells, caspase-4 was highly expressed in the 
SSa-sensitive H358 cell line. Caspase-4 expression was 
lowest in breast cancer cell lines compared to in other 
cell types tested. As an exception, some leukemia cells 
that are resistant to SSa treatment had high caspase-4 
expression. Given the high basal expression of caspase-4 
in colon cancer cells and given that SSa induces 
colon cancer-specific apoptosis and triggers caspase-4 
cleavage and activation, we hypothesized that altered 
expression of caspase-4 may be an underlying cause of 
the selective effects of SSa. However, due to discrepancies 
between caspase-4 expression and SSa sensitivity, other 
possibilities cannot be excluded.
Another hypothesis we tested was whether the 
constitutive activation of NF-κB in HCC cells is a cause 
of the specific sensitivity of colon cancer cells to SSa-
induced cytotoxicity. It has been reported that NF-κB is 
constitutively activated in most colon cancer cells [46]. 
Moreover, Din et al. reported that the effect of aspirin on 
NF-κB signaling is implicated in the specific sensitivity 
of colon cancer cells to aspirin-induced apoptosis [47]. 
We examined the effect of SSa on the NF-κB signaling 
pathway and found that SSa treatment induced significant 
IκBα (the NF-κB inhibitory protein) phosphorylation at 
Ser32 in SSa-sensitive colon cancer cells (LoVo, SW480, 
Figure 6: Caspase-4 plays a role in SSa-induced DNA damage response. LoVo and SW480 cells were exposed to 20 μM SSa 
for 15 h in the presence or absence of z-LEVD-fmk (10 μM). (A) The percentage of cells positive for γ-H2AX foci was calculated as in 
Figure 5D. Results are mean ± standard error for three experiments. **P < 0.01 compared with untreated controls. †P < 0.05 and ††P < 0.01 
compared with SSa alone. ANOVA and Tukey’s test were used for statistical analysis. (B) Western blotting was used to detect H2AX 
phosphorylation at Ser139. Blots are representative of three independent experiments, and data shown represent the mean ± standard error 
of three independent experiments. **P < 0.01 compared with untreated controls. ††P < 0.01 compared with SSa alone. ANOVA and Tukey’s 
test were used for statistical analysis.
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HT29, SW620) but not in SSa-resistant cells of other 
cancer types (H1299, Hs 578T, U937) (data not shown). 
Given that SSa-induced IκBα phosphorylation is generally 
restricted to colon cancer cells, we think that the sensitive 
response of the NF-κB pathway to SSa in colon cancer 
cells might be another underlying cause of the selective 
effects of SSa. Furthermore, it has been reported that 
enhancement of NF-κB activity increases the expression 
of caspase-4, both in terms of mRNA and protein [48]. 
Further studies into possible interactions between the 
effects of SSa on the NF-κB pathway and the effects of 
SSa on caspase-4 activation and apoptosis in cancer cells 
are in progress.
We assessed the role of caspase-4 in SSa-induced 
caspase activation and found inhibition of caspase-4 
activation using z-LEVD-fmk (irreversible), Ac-LEVD-
CHO (reversible), or RNA interference (siRNA), was 
associated with reduced activation of caspase-3, -8, and 
-2. However, inhibition of caspase-3, -8, and -2 using 
pharmacological inhibitors (z-DEVD-fmk, z-IETD-fmk, 
or z-VDVAD-fmk) or specific siRNAs did not lead to 
changes in caspase-4 activity. These findings suggest that 
caspase-4 activation is an important step in SSa-induced 
activation of caspase-2, -8 and -3. This is the first time 
caspase-2 has been identified as a novel substrate of 
caspase-4.
Even though caspase-4 and caspase-2 are typically 
classified as ‘inflammatory’ and ‘initiator’ caspases, 
respectively, these two proteins have similar domain 
structures. Both have caspase activation and recruitment 
domain (CARD domain), an interaction motif involved 
in processes related to inflammation and apoptosis [49, 
50], in the N-terminal region. Since the CARD domain 
typically associates with CARD-containing proteins, this 
suggests that caspase-4 and caspase-2 have the potential 
to interact with each other. In addition, given that CARD-
containing proteins are associated with immune responses, 
this suggests that SSa may also cause an immune response. 
Further studies are needed to investigate these issues.
We also assessed the role of caspase-4 in SSa-
induced apoptosis using siRNA and the selective synthetic 
peptide caspase-4 inhibitors, z-LEVD-fmk and Ac-LEVD-
CHO. Sub-G1 fraction analysis and Hoechst 33342 
staining revealed that both caspase-4 inhibitors blocked 
the formation of sub-diploid DNA and apoptotic nuclei to 
a significant extent, indicating that caspase-4 is required 
for SSa-induced apoptosis. Moreover, siRNA knockdown 
of caspase-4 significantly decreased the numbers of 
hypodiploid cells and cells with condensed/fragmented 
nuclei, consistent with previous results. Clonogenicity is 
the degree to which a cell can form colonies in culture 
and is an indicator of the long-term survival of a cell. 
Interestingly, clonogenic assays showed that colony 
formation decreased for approximately 2 weeks following 
SSa treatment and was suppressed significantly by 
caspase-4 inhibition. Therefore, caspase-4 inhibition was 
correlated with enhanced clonogenic survival in colon 
cancer cells. However, caspase-12, another ER-resident 
caspase, did not seem to be involved in SSa-triggered 
apoptosis or clonogenic cell death, as evidenced by 
z-ATAD-fmk (caspase-12 inhibitor) not attenuating SSa-
induced apoptosis or clonogenic cell death.
Caspase-12 also has a CARD domain. However, 
caspase-12 was not required for SSa-induced apoptosis; 
therefore, the CARD domain by itself does not explain 
the critical role of caspase-4 and/or the dispensable role 
of caspase-12 in SSa-induced apoptosis. Since initiator 
caspases activate other downstream caspases through their 
proteolytic activity, it is possible that the protease activity 
of caspase-4 is implicated in SSa-induced apoptosis and 
caspase activation. Similarly, human caspase-12 has 
no protease activity, even though it is highly related to 
members of the ICE subfamily.
We showed previously that SSa could activate 
caspase-2 activity [14]; as caspase-2 functions in 
response to DNA damage [19, 20], we also evaluated 
whether SSa induces DNA damage. CBMN, comet, and 
H2AX foci assays showed that SSa caused significant 
DNA damage in cancer cells. The tumor suppressor p53 
protein primarily induces apoptosis in the DNA damage 
response. We assessed the expression of p53 and its 
apoptotic transcriptional target, bax after SSa treatment 
and found that SSa did not increase the expression of 
these proteins (data not shown). Furthermore, in our 
previous experiments using p53 wild-type HCT116 and 
p53-/- HCT116 cells, we reported that the cytotoxic effect 
of SSa does not differ between these two cell types [14]. 
Collectively, these results indicate that SSa-induced 
cytotoxicity does not require p53 induction following 
DNA damage.
Given the role of caspase-4 in SSa-mediated 
caspase-2 activation and the role of caspase-2 in the DNA 
damage response, we investigated whether caspase-4 is 
involved in SSa-induced DNA damage. The formation 
of SSa-induced γ-H2AX foci, a marker of DNA 
damage, was reduced significantly after pretreatment 
with caspase-4 inhibitor. Because activated caspase-3 
cleaves ICAD (inhibitor of caspase-activated DNase) 
and releases active CAD (caspase-activated DNase) from 
ICAD, which then cleaves DNA and provokes H2AX 
phosphorylation, the DNA damage we observed may be 
an effect rather than a cause of SSa-mediated apoptosis. 
To assess this possibility, we investigated whether 
pretreatment with inhibitors of caspase-3, as well as 
caspase-2 and -8, rescues SSa-induced DNA damage; 
none of these inhibitors were able to reduce SSa-induced 
H2AX phosphorylation (data not shown). Therefore, we 
hypothesize that SSa-induced DNA damage is a cause of 
SSa-induced apoptosis and that caspase-4 is an important 
regulator of this process. Further studies investigating 
linkage between the DNA damage response pathway and 
caspase-4 activation are warranted.
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Taken together, these results suggest that sequential 
activation of caspase-4, -2, -8, and -3 is important for SSa-
induced cancer cell apoptosis. Furthermore, caspase-4 
plays an important role in the SSa-induced DNA damage 
response pathway and caspase-2 activation. Overall, our 
data suggest a model in which SSa induces colon cancer 
cell apoptosis via caspase-4 activation, followed by DNA 
damage and/or sequential activation of caspase-2, -8, 
and -3 (Supplementary Figure 11). Considering that SSa 
cytotoxicity is cell type-dependent, a tailor-made approach 
using SSa should be pursued in the development of cancer 
treatments.
MATERIALS AND METHODS
Reagents
Saikosaponin (SSa; Nacalai Tesque Inc., Kyoto, 
Japan) was dissolved in DMSO (Sigma Chemical Co., 
St. Louis, MO) to form a 10-mM stock solution and 
stored at –20°C until use. Propidium iodide (PI), RNase 
A, Hoechst 33342, cytochalasin-B, Giemsa stain, and 
4’,6-diamidino-2-phenylindole (DAPI) were purchased 
from Sigma. Caspase colorimetric assay kits were 
purchased from BioVision (Palo Alto, CA). Caspase-4 
inhibitors, z-LEVD-fmk and Ac-LEVD-CHO, were 
obtained from Enzo Life Sciences (Plymouth Meeting, 
PA). The caspase-12 inhibitor, z-ATAD-fmk, was obtained 
from BioVision. z-DEVD-fmk (caspase-3 inhibitor), 
z-VDVAD-fmk (caspase-2 inhibitor), and z-IETD-fmk 
(caspase-8 inhibitor) were obtained from Calbiochem 
(La Jolla, CA). The annexin V-fluorescein isothiocyanate 
(FITC) apoptosis detection kit was purchased from BD 
Biosciences (Franklin Lakes, NJ, USA).
Cell culture
Human colon carcinoma (HCC; HCT116, LoVo, 
HT-29, SW48, SW480, and SW620), human lung cancer 
(H460, A549, H520, H358, and H1299), human breast 
cancer (BT20, Hs 578T, MCF7, and MDAMB231), and 
human leukemia cell lines (HL-60, Jurkat, MOLT-4, 
U937, and K562) were obtained from the American Type 
Culture Collection (ATCC, Manassas, VA). Cells were 
grown in DMEM or RPMI 1640 medium supplemented 
with 10% fetal bovine serum (FBS), 100 U/mL penicillin, 
and 100 μg/mL streptomycin (all from GIBCO, Invitrogen, 
Carlsbad, CA). The cultures were maintained at 37°C 
under an atmosphere of 5% CO2.
Treatment with SSa and caspase inhibitors
For caspase activity assays, SW480 cells were 
pretreated with caspase inhibitors (z-DEVD-fmk, 
z-VDVAD-fmk, z-IETD-fmk, or z-LEVD-fmk; 10 μM) or 
vehicle (DMSO) for 1 h, and then treated with 20 μM SSa. 
For apoptosis and colony formation assays, two HCC cell 
lines (LoVo and SW480) were pretreated with caspase-4 
inhibitors (z-LEVD-fmk or Ac-LEVD-CHO; 10 μM), 
caspase-12 inhibitor (z-ATAD-fmk; 10 μM), or vehicle 
(DMSO for z-LEVD-fmk and z-ATAD-fmk or DDW for 
Ac-LEVD-CHO) for 1 h and then treated with 20 μM SSa. 
The time of SSa treatment is given in each figure legend.
Cell viability assay
Following SSa treatment, the rate of cell survival 
was determined using a Trypan Blue exclusion assay. In 
this assay, viable cells exclude Trypan Blue dye. HCC 
(HCT116, LoVo, HT-29, SW48, SW480, and SW620), 
human lung cancer (H460, A549, H520, H358, and 
H1299), human breast cancer (BT20, Hs 578T, MCF7, 
and MDAMB231), and human leukemia (HL-60, Jurkat, 
MOLT-4, U937, and K562) cell lines were treated with 
20 μM SSa for up to 40 h. Prior to SSa treatment, cell 
viability was verified by trypan blue exclusion and was 
routinely over 97%. The observed percentage of live cells 
is indicated in each Figure.
Tumor growth-delay assay
Flank xenografts were established in 6-week-old 
female athymic BALB/c nude mice by subcutaneous 
injection of 2×106 LoVo and SW480 cells resuspended in 
0.1 ml of PBS. Tumors were allowed to grow for 7 days 
before treatment. The mice were randomized into two 
groups (DMSO vehicle treatment and SSa treatment) of 
five mice each. SSa was solubilized in 10% DMSO in 
PBS, pH 7.4, immediately before each treatment, and SSa 
or the vehicle was administered to mice by intraperitoneal 
injection at a dose of 2 mg/kg once per week. Tumors were 
measured every 3 days with calipers in a blind fashion, 
and tumor volume was calculated as the largest diameter 
(mm) × smallest diameter2 (mm2)/2. Mice were treated 
only after obtaining approval from the Yonsei University 
Animal Care and Use Committee, and experiments were 
carried out according to relevant guidelines.
Quantitative RT-PCR assay for detection of the 
mRNA of ER stress-induced genes
Total RNA was isolated from HCC cells using 
an RNeasy Mini Kit (Qiagen) according to the 
manufacturer’s instructions. cDNAs were synthesized 
using the iScriptTM cDNA synthesis kit (Bio-Rad). 
To determine mRNA levels of PERK, CHOP, ATF4, 
and XBP1, quantitative RT-PCR was performed on a 
Mastercycler ep realplex thermal cycler (Eppendorf), in 
a total volume of 20 μl containing 200 nM primers and 
1× ABsolute Blue QPCR SYBR Green Mix (ABgene). 
For human PERK amplification, primers hPERK-F 
(5’-ATGAGACAGAGTTGCGACCG-3’) and hPERK-R 
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(5’-TGCTAAGGCTGGATGACACC-3’) were used. 
For human CHOP amplification, primers hCHOP-F 
(5’-ACAGAGTGGTCATTCCCCAGCC-3’) and 
hCHOP-R (5’-TTCGGTCAATCAGAGCTCGGCG-3’) 
were used. For human ATF4 amplification, primers 
hATF4-F (5’-GCCAAGCACTTCAAACCTC-3’) and 
hATF4-R (5’-ATCTATACCCAACAGGGCATC-3’) were 
used. For human XBP1 amplification, primers hXBP1-F 
(5’-CAGAGATCGAAAGAAGGCTC-3’) and hXBP1-R 
(5’-CAAGCGCTGTCTTAACTCC-3’) were used. 
For human GAPDH amplification, primers hHPRT-F 
(5’-TGGCGTCGTGATTAGTGATG-3’) and hHPRT-R 
(5’-GCTACAATGTGATGGCCTCC-3’) were used.
Assessment of caspase activity
Caspase colorimetric assay kits (BioVision) were 
used to determine the enzymatic activities of caspases 
(caspase-3, -4, -2, and -8). Cell lysates were prepared in 
the lysis buffer provided by the manufacturer. Lysates 
were normalized for protein content and then incubated 
with labeled substrates at 37°C for 2 h. Caspase activity 
was measured by spectrophotometric detection of the 
chromophore p-nitroanilide (pNA) at 405 nm after 
cleavage from the substrate.
siRNA transfection targeting caspase-4
LoVo and SW480 cells, which were ~30% confluent 
on the day of transfection, were transiently transfected 
with small interfering RNA (siRNA) against caspase-4 
using Lipofectamine RNAiMAX Reagent (Invitrogen) 
according to the manufacturer’s protocol. Control treated 
cells were exposed only to the transfection reagent, and 
negative control cells were transfected with scrambled 
siRNA against caspase-4. Thirty hours after transfection, 
cells were challenged with 20 μM SSa. The caspase-4 
siRNA sequence was ACAGCTGTTGTTGAGCGAA, 
and the scrambled siRNA sequence was 
GAUCAUACGUGCGAUCAGA. All siRNAs were 
designed using Rosetta with a proprietary algorithm.
Flow cytometric detection of the sub-G1 fraction
LoVo and SW480 cells were treated with various 
concentrations of SSa for 30 h in the presence or 
absence of caspase-4 inhibitors (z-LEVD-fmk or Ac-
LEVD-CHO), caspase-12 inhibitor (z-ATAD-fmk), or 
caspase-4 siRNA. Cellular DNA was stained with PI 
and quantified by sub-G1 fluorescence-activated cell 
sorting (FACS) analysis using a FACScan flow cytometer 
(Becton Dickinson, Franklin Lakes, NJ). Cells were fixed 
in ice-cold 70% ethanol, washed twice with PBS, and 
then stained with 50 ithmL PI and 100 μg/mL RNase A. 
The cell suspension was incubated in the dark at room 
temperature for 30 min, and 10,000 cells were measured 
per sample. Analyses were performed using Cell Quest 
Pro software (Becton Dickinson).
Assessment of apoptotic nuclear morphology
LoVo and SW480 cells were treated with various 
concentrations of SSa for 24 h in the presence or absence 
of caspase-4 inhibitors (z-LEVD-fmk or Ac-LEVD-CHO), 
caspase-12 inhibitor (z-ATAD-fmk), or caspase-4 siRNA. 
Following fixation in 4% paraformaldehyde in PBS for 
10 min at room temperature, cells were incubated in 2 
μg/mL Hoechst 33342 for 30 min in the dark. More than 
200 cells were observed under a fluorescence microscope 
and assessed for morphological features of apoptosis. 
Apoptotic nuclei were identified by the presence of 
condensed chromatin around the periphery of the nuclear 
membrane or totally fragmented nuclear bodies.
Assessment of annexin V/PI double staining
LoVo and SW480 cells were treated with various 
concentrations of SSa for 24 h. Cells were stained with 
annexin V-FITC and PI (both from BD Biosciences) for 
15 min at room temperature in annexin V binding buffer, 
then analyzed using flow cytometry (Becton Dickinson, 
Franklin Lakes, NJ). Emissions from annexin V and PI 
were detected in the FL-1 and FL-2 channels, respectively. 
For each sample, data from 10,000 cells were recorded in a 
list using logarithmic scales. Data analysis was conducted 
using Cell Quest Pro software (Becton Dickinson). 
Annexin V positive results indicate apoptotic cells.
Colony formation assay
LoVo and SW480 cells were trypsinized, counted, 
and plated into 60-mm dishes at a density of 500 cells/
dish. Cells were treated with 15 μM SSa for 12–14 d to 
allow for colony formation in the presence or absence of 
caspase-4 inhibitors (z-LEVD-fmk or Ac-LEVD-CHO). 
After incubation, colonies were fixed and stained with 1% 
methylene blue in 50% ethanol at room temperature, and 
colonies consisting of more than 100 cells per plate were 
counted.
Cytokinesis-block micronucleus (CBMN) assay
LoVo and SW480 cells were treated with 20 μM 
SSa for up to 15 h and then with cytochalasin-B (4 μg/
mL; Sigma) for 28 h to inhibit cell division. Cytokinesis-
block micronucleus (CBMN) preparations were prepared 
according to a modified version of the method developed 
by Fenech and Morley [51]. Cells were harvested for slide 
preparation, fixed in methanol for 15 min, air-dried, and 
then stained in 5% Giemsa solution. After staining, the 
slides were rinsed in water, air-dried, and mounted with 
cover slips. Slides were examined with a Leica DMLB 
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optical microscope (Leica Microsystems AG, Wetzlar, 
Germany) at 40× magnification. Scoring was conducted 
based on the criteria established by Fenech [52]. In total, 
1000 binucleated cells were scored. All slides were coded 
and scored blindly.
Single-cell gel electrophoresis (SCGE, comet) assay
LoVo and SW480 cells were treated with 20 μM SSa 
for up to 15 h. After treatment, neutral [for double-strand 
breaks (DSBs)] and alkaline [for single-strand breaks 
(SSBs) and DSBs] single-cell gel electrophoresis (SCGE, 
comet) assays were performed using a Trevigen comet 
assay kit (Trevigen, Inc., Gaithersburg, MD). Cells were 
mixed with molten low-melting point agarose at 37°C at 
a 1:10 (v/v) ratio and spread immediately onto frosted 
microscope slides. The slides were incubated at 4°C for 
20 min and then immersed in lysis solution at 4°C for 1 
h. For the alkaline assay, slides were immersed in freshly 
prepared alkaline unwinding solution (pH>13) at 4°C for 1 
h, followed by alkaline electrophoresis for 30 min at 21 V 
(1 V/cm). After electrophoresis, slides were washed twice 
by immersion in distilled water for 10 min, followed by 
immersion in 70% ethanol for 5 min. For the neutral assay, 
slides were immersed in neutral electrophoresis buffer at 
4°C for 30 min, followed by neutral electrophoresis for 
45 min at 21 V (1 V/cm). After electrophoresis, slides 
were immersed in DNA precipitation solution for 30 min 
at room temperature, then in 70% ethanol for 30 min. 
DNA was stained with SYBR Green and examined using 
Komet 5.5 imaging software. The Olive tail moment 
(OTM), defined as the product of the percentage of DNA 
in the tail and the displacement between the position of 
the mean center of mass in the heads and tails, was used 
as a measure of DNA damage. Two hundred comets were 
evaluated per sample.
Immunostaining for γ-H2AX foci
LoVo and SW480 cells were treated with 20 μM 
SSa for 15 h in the presence or absence of z-LEVD-fmk 
(caspase-4 inhibitor), then fixed in 4% paraformaldehyde 
at 4°C for 15 min. The fixed cells were permeabilized 
in PBS containing 100 mM Tris-HCl, 50 mM 
ethylenediamine tetra-acetic acid (EDTA), and 0.5% 
Triton X-100 for 15 min at room temperature. Cells 
were incubated with phospho-H2AX (ab2893; Abcam, 
Cambridge, UK) primary antibody diluted to a 1:100 
ratio at 4°C overnight and then detected with AlexaFluor 
594-conjugated anti-rabbit secondary antibody (A-11037; 
Molecular Probes, Eugene, OR, USA). Slides were 
counterstained with DAPI, and images were acquired 
on an ECLIPSE E600 fluorescence microscope (Nikon, 
Tokyo, Japan). Cells were classified as ‘positive’ when 
more than three H2AX foci were observed per cell.
Immunoblot analysis
Cells were solubilized in lysis buffer [50 mM 
Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1% 
Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 
and 1 mM DTT] containing protease and phosphatase 
inhibitor cocktails (both from Sigma). Following 
centrifugation, the concentration of protein in the soluble 
faction was determined using the Bradford assay (Bio-
Rad Laboratories, Hercules, CA). Protein samples were 
loaded into a SDS-polyacrylamide gel (10 μg/lane), 
separated by SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE), transferred onto polyvinylidene fluoride 
(PVDF) membrane (NEN, PerkinElmer, Wellesley, 
MA), and probed with specific antibodies against the 
following proteins (the epitope and catalog numbers are 
listed in parentheses): p-PERK (Thr981) (sc-32577), 
cleaved-caspase-4 (sc-22174; Santa Cruz Biotechnology, 
Santa Cruz, CA); p-eIF2α (Ser51) (9721), CHOP (2895), 
pro-caspase-4 (4450), caspase-2 (2224), caspase-8 
(9746), p-H2AX (Ser139) (2577), actin (3700; Cell 
Signaling Technology, Danvers, MA, USA); t-Bid (44-
433G; Biosource, Bethesda, MD), and pro-caspase-12 
(ab62484; Abcam, Cambridge, UK). Primary antibodies 
were detected using horseradish peroxidase-conjugated 
secondary antibodies and visualized using a Western 
Lightning Plus-ECL (Perkin Elmer, Waltham, MA) 
chemiluminescence system. The results of immunoblotting 
were quantified by densitometry and analyzed using 
ImageQuant software. Data were normalized for actin 
levels and expressed using arbitrary units.
Statistical analysis
Statistical analyses were performed using SAS 
8.1 software for Windows (SAS Institute, Inc., Cary, 
NC). All experiments were conducted in triplicate and 
results are presented as the mean ± standard error. Data 
were evaluated using the Mann-Whitney U test for 
comparison between two independent groups or one-way 
analysis of variance (ANOVA) with Tukey’s post hoc 
test for multiple comparisons. P < 0.05 was considered 
statistically significant, and P < 0.01 was considered 
highly statistically significant.
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